Biomaterial-associated factors in silicone breast implant-related pathology
Acta Biomaterialia · 2026-10 · 223 · 23-40
DOI: 10.1016/j.actbio.2026.08.039 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Acta Biomaterialia, 2026-10. Verfasst von Neal I Callaghan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Dalhousie University, Halifax, NS, B3H 4R2, Canada; Nova Scotia Health, Halifax, NS, B3S 0H6, Canada. Hauptthemen laut MEDLINE: Breast Implants, Silicones, Biocompatible Materials, Foreign-Body Reaction. Die Arbeit nennt 229 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Sciences and Engineering Research Council of Canada, Canadian Institutes of Health Research.
Abstract (Originalsprache)
Silicone breast implants (SBIs) are among the most common surgically-implantable medical devices, but carry high complication rates, especially in the setting of post-oncologic breast reconstruction. These complications include capsular contracture, malposition, rupture, and breast implant-associated anaplastic large cell lymphoma. The development of SBI-associated complications is recognized to be multifactorial with the underlying mechanisms being poorly defined. Physical factors implicated in pathophysiology include gross mechanical stresses induced by the implant on surrounding tissue, the dissipation of friction stresses to local tissue by implant microtopography, and the incongruity of stiffness between local breast tissue, fibrous capsular tissue, and biomaterial, causing a significant gradient at the interface. Hypotheses of implicated (bio)chemical factors include direct adjuvant activity of the silicone material, the adsorption and persistence of pro-inflammatory factors at the interface, and the seeding of bacterial colonies. The current review explores in detail the physiology of the specific foreign body response to implanted materials associated with clinical SBIs, including the available evidence implicating both physical and chemical factors in the propagation of pathology. New advances in models and materials-based approaches to assessing and mitigating material-induced pathology are also reviewed. Finally, recommendations for SBI design, as well as further mechanistic work to address the pathophysiology underlying SBI-associated complications are outlined. STATEMENT OF SIGNIFICANCE: Treatment for breast cancer is associated with significant morbidity between surgical, radiotherapeutic, and systemic therapeutic approaches. Silicone breast reconstructive devices can allow for patients to regain confidence and personal efficacy after the trauma of cancer treatment. However, these devices are notorious for immune-mediated foreign body reactions, and patients can then suffer from painful or disfiguring fibrosis, and rarely a subtype of lymphoma or whole-body autoimmune reactions. Despite the ubiquity of these devices, the pathophysiological mechanisms underlying these complications are poorly understood. In this review, we review both clinical and fundamental approaches to understanding the development of pathology related to breast reconstructive devices, and discuss potential physicochemical approaches to device composition that may minimize these risks in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Dalhousie University, Halifax, NS, B3H 4R2, Canada; Nova Scotia Health, Halifax, NS, B3S 0H6, Canada.
- Nova Scotia Health, Halifax, NS, B3S 0H6, Canada; Department of Family Medicine, Dalhousie University, Halifax, NS, B3H 4R2, Canada.
- Department of Microbiology & Immunology, Faculty of Medicine, Dalhousie University, Halifax, NS, B3H 4R2, Canada.
- School of Biomedical Engineering, Faculties of Medicine and Engineering, Dalhousie University, Halifax, NS, B3H 4R2, Canada.
- Nova Scotia Health, Halifax, NS, B3S 0H6, Canada; Division of Plastic Surgery, Dalhousie University, Halifax, NS, B3H 4R2, Canada; IWK Health Centre, Halifax, NS, B3K 6R8, Canada.
- Nova Scotia Health, Halifax, NS, B3S 0H6, Canada; Department of Microbiology & Immunology, Faculty of Medicine, Dalhousie University, Halifax, NS, B3H 4R2, Canada; School of Biomedical Engineering, Faculties of Medicine…
Förderung
- Natural Sciences and Engineering Research Council of Canada
- Canadian Institutes of Health Research
Zitieren
APA
Callaghan, N. I., Lake, R., Fong-Hollohan, L., Medd, K., Rempe, C., Bezuhly, M., & Davenport Huyer, L. (2026). Biomaterial-associated factors in silicone breast implant-related pathology. Acta Biomaterialia, 223, 23-40. https://doi.org/10.1016/j.actbio.2026.08.039
Vancouver
Callaghan NI, Lake R, Fong-Hollohan L, Medd K, Rempe C, Bezuhly M, et al. Biomaterial-associated factors in silicone breast implant-related pathology. Acta Biomaterialia. 2026;223:23-40. doi:10.1016/j.actbio.2026.08.039
BibTeX
@article{Callaghan2026,
author = {Callaghan, Neal I and Lake, Robin and Fong-Hollohan, Lauren and Medd, Kyle and Rempe, Christian and Bezuhly, Michael and Davenport Huyer, Locke},
title = {Biomaterial-associated factors in silicone breast implant-related pathology},
journal = {Acta Biomaterialia},
year = {2026},
volume = {223},
pages = {23--40},
doi = {10.1016/j.actbio.2026.08.039}
}
EUVIMED